Wilmington Pharmaceuticals develops and licenses formulations for drug developments.
Business Model:
Revenue: $11.9M
Employees: 51-200
Address: 1213 Culbreth Dr
City: Wilmington
State: NC
Zip: 28405
Country: US
At Wilmington Pharmaceuticals, they develop and out-license patient-friendly, fast-dissolving formulations for established medicines. They achieve FDA approval and rapid commercialization for their licensing partners, minimizing regulatory risk while maximizing economic opportunity. Their points of differentiation provide you with an ideal development partner.
Contact Phone:
+19105090097
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2006 | Series B | $0 |
Emergent Growth Fund Wilmington Investor Network Emergent Growth Fund Wilmington Investor Network |
10/2006 | Series B | 2 | $1.3M |
Emergent Growth Fund Wilmington Investor Network Emergent Growth Fund Wilmington Investor Network |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|